JPS5913210B2 - Method for manufacturing film-type collagen artificial skin - Google Patents
Method for manufacturing film-type collagen artificial skinInfo
- Publication number
- JPS5913210B2 JPS5913210B2 JP50057870A JP5787075A JPS5913210B2 JP S5913210 B2 JPS5913210 B2 JP S5913210B2 JP 50057870 A JP50057870 A JP 50057870A JP 5787075 A JP5787075 A JP 5787075A JP S5913210 B2 JPS5913210 B2 JP S5913210B2
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- film
- solution
- artificial skin
- crosslinking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000008186 Collagen Human genes 0.000 title claims description 49
- 108010035532 Collagen Proteins 0.000 title claims description 49
- 229920001436 collagen Polymers 0.000 title claims description 49
- 238000000034 method Methods 0.000 title claims description 12
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 238000004132 cross linking Methods 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 7
- 239000011550 stock solution Substances 0.000 claims description 7
- 150000001299 aldehydes Chemical class 0.000 claims description 6
- 238000007605 air drying Methods 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 8
- 208000027418 Wounds and injury Diseases 0.000 description 8
- 238000011282 treatment Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 235000011941 Tilia x europaea Nutrition 0.000 description 3
- 239000004571 lime Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003431 cross linking reagent Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000005661 hydrophobic surface Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Description
【発明の詳細な説明】
本発明はコラーゲン物質を原料とする人工皮膚の製造法
に関し、更に詳細にはコラーゲン繊維の水系分散液とコ
ラーゲン水溶液とからなる原液を濃厚無機塩類水溶液中
に管状または平面状に押出して凝固させるか又は支持体
上に直接流し込み乾燥した後、アルデヒド類を用いるか
または紫外線を照射して架橋するフィルムタイプのコラ
ーゲン製人工皮膚の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing artificial skin using a collagen material as a raw material, and more specifically, a method for producing artificial skin using a collagen material as a raw material. The present invention relates to a method for producing a film-type artificial skin made of collagen, which is formed by extruding it into a shape, solidifying it, or pouring it directly onto a support, drying it, and then crosslinking it using an aldehyde or by irradiating it with ultraviolet rays.
外科及び整形外科領域において、広範な外傷性皮膚欠損
を起すことが非常に多い。Extensive traumatic skin defects are very common in the surgical and orthopedic field.
これに対する治療法においてすでに実用されているもの
は軟膏、リパノールガーゼなどであり、最近ではソフラ
チユールガーゼ、フィブリン膜等が用いられるようにな
つてきた。しかしこれらにはそれぞれ一長一短があり必
ずしも満足できるものではない。本発明方法によつて製
造されたコラーゲン製人工皮膚は人間を含む動物の外傷
、火傷、移植皮膚採取後の創傷などに用いて従来治療法
に比較して格段に良好な治療効果が見出された。本発明
の発明者は生体の構成する生体蛋白であるコラーゲンを
用いて、コラーゲン製人工皮膚を製造することに着目し
た。Treatments for this have already been put into practical use, such as ointments and lipanol gauze, and recently, sophranol gauze, fibrin membranes, etc. have come into use. However, each of these has advantages and disadvantages, and is not necessarily satisfactory. The collagen artificial skin produced by the method of the present invention has been found to have significantly better therapeutic effects than conventional treatment methods when used for wounds, burns, and wounds after harvesting skin grafts in animals including humans. Ta. The inventors of the present invention focused their attention on producing artificial skin made of collagen using collagen, which is a biological protein that is a constituent of living organisms.
元来コラーゲンは動物の骨並に皮膚を構成する主要蛋白
であり、細胞培養の際の基盤として使用して細胞生育に
効果があり、また偽内膜生成に対しても効果がある。近
年コラーゲンは透析膜、人工角膜、人工硝子体、縫合糸
、人工血管、止血スポンジなど医学への応用が盛んであ
り、多くの利点があるユニークな生体材料として注目さ
れており、工業原料としても多量に製造することができ
る。本発明に使用するコラーゲン繊維分散液は次のよう
に製造できる。Collagen is originally a major protein that constitutes the bones and skin of animals, and is effective for cell growth when used as a base for cell culture, and is also effective against pseudoendometrial formation. In recent years, collagen has been widely used in medical applications such as dialysis membranes, artificial corneas, artificial vitreous bodies, sutures, artificial blood vessels, and hemostatic sponges, and is attracting attention as a unique biomaterial with many advantages.It is also used as an industrial raw material. Can be manufactured in large quantities. The collagen fiber dispersion used in the present invention can be produced as follows.
動物生皮例えば牛皮を洗浄してフレツシングマシンにか
け肉面を除去した後、酵素又は石灰により脱毛し28℃
以下の温度で石灰液(CaCOH)2の濃度0.5〜3
0%)に1〜30日間浸漬する。場合によつては石灰処
理を省略することもできる。洗浄後アルカリを中和し、
更に有機酸もしくは無機酸の水溶液例えば乳酸0.5〜
5%水溶液中に20℃以下で1〜10日間浸漬して酸膨
潤を行う。酸膨潤した皮を機械的に微細化又は解繊し、
均一な糊状物質を得る。この糊状物質を更に稀酸で稀釈
して均一分散を施しコラーゲン濃度0.2−6%のコラ
ーゲン繊維分散液とする。又は脱毛後の皮を洗浄し、ア
ルカリを中和した後の中性皮を機械的に微細化及び均一
分散化し、次いで有機酸もしくは無機酸水溶液、例えば
0.5〜5%乳酸水溶液にてコラーゲン濃度0.2〜6
%となるよう稀釈混合し且つ均一分散化してコラーゲン
繊維分散液とする。一方、本発明に使用するコラーゲン
水溶液は動物生皮特に精製牛皮を公知の方法(例えば特
公昭37−14426、46一15033号公報に記載
されている)で処理して製造できる。本発明はこのよう
に製造したコラーゲン水溶液を単独で使用するか、また
は前記コラーゲン水溶液を前記分散液の乾燥コラーゲン
に基き前記溶液の乾燥コラーゲン重量が20−100%
になるように混合分散してコラーゲン濃度0.2′−6
%の混合液を生成し、これを成形原液とする。これらの
原液を環状ノズルまたはスリットノズルより管状または
平面状に濃厚塩類溶液(例えば食塩15%以上、硫安1
5%以上)中に吐出凝固させるか風乾法によりフィルム
を作る。スリットノズルより平面状に吐出凝固させたも
のは疎水性表面をもつ平滑なベルトコンベア上に連続的
に流して乾燥させることもできる。乾燥したコラーゲン
フィルムは慣用法によりコラーゲン分子間の架橋を行つ
た。架橋は第1表に示すように架橋剤水溶液で処理する
か、または紫外線照射によつて行うことができる。架橋
剤水溶液とはアルデヒド類の水溶液である。Animal rawhide, such as cowhide, is washed and put through a fretting machine to remove the meat side, and then dehaired with enzymes or lime at 28°C.
Concentration of lime solution (CaCOH)2 at the following temperature: 0.5-3
0%) for 1 to 30 days. In some cases, lime treatment may be omitted. After cleaning, neutralize the alkali,
Furthermore, an aqueous solution of an organic or inorganic acid, such as lactic acid 0.5~
Acid swelling is performed by immersing in a 5% aqueous solution at 20° C. or lower for 1 to 10 days. Mechanically micronize or defibrate the acid-swollen skin,
A homogeneous pasty substance is obtained. This paste-like material is further diluted with dilute acid to uniformly disperse it to obtain a collagen fiber dispersion having a collagen concentration of 0.2-6%. Alternatively, the skin after hair removal is washed, the neutral skin after neutralizing the alkali is mechanically finely divided and uniformly dispersed, and then collagen is added to an organic or inorganic acid aqueous solution, such as a 0.5 to 5% lactic acid aqueous solution. Concentration 0.2-6
% and uniformly dispersed to obtain a collagen fiber dispersion. On the other hand, the collagen aqueous solution used in the present invention can be produced by treating animal rawhide, particularly purified cowhide, by a known method (for example, as described in Japanese Patent Publication No. 37-14426, No. 46-15033). In the present invention, the collagen aqueous solution prepared as described above is used alone, or the collagen aqueous solution is prepared based on the dry collagen of the dispersion, and the dry collagen weight of the solution is 20-100%.
Mix and disperse so that the collagen concentration is 0.2'-6
% mixed solution is produced and this is used as the stock solution for molding. These stock solutions are poured into a tubular or planar shape through an annular nozzle or a slit nozzle using a concentrated salt solution (for example, 15% or more of common salt, 1% or more of ammonium sulfate).
5% or more) to form a film by discharging and coagulating it or by air drying. The solidified material discharged into a flat shape from a slit nozzle can also be dried by continuously flowing it onto a smooth belt conveyor with a hydrophobic surface. The dried collagen film was subjected to crosslinking between collagen molecules using a conventional method. Crosslinking can be carried out by treatment with an aqueous crosslinking agent solution as shown in Table 1 or by irradiation with ultraviolet light. The crosslinking agent aqueous solution is an aqueous solution of aldehydes.
使用するアルデヒドがホルムアルデヒドの場合には約0
.05〜2.0q6のホルムアルデヒドを含有しかつ中
性塩を共存させたPH8〜10の水溶液であり、グルタ
ルアルデヒドを使用する場合には該アルデヒドを0.0
01〜0.1%含有し中性塩を共存させたPH4〜6の
水溶液である。いずれの場合においても、架橋処理は約
30℃で2〜20時間行う。乾燥後におけるコラーゲン
フィルムへのアルデヒドの結合量はホルムアルデヒドで
は0.2〜2.0重量%、グルタルアルデヒドでは0.
2〜5重量%である。Approximately 0 when the aldehyde used is formaldehyde
.. It is an aqueous solution with a pH of 8 to 10 containing 0.05 to 2.0q6 formaldehyde and coexisting with a neutral salt, and when using glutaraldehyde, the aldehyde is 0.0
It is an aqueous solution with a pH of 4 to 6 containing 01 to 0.1% and coexisting with a neutral salt. In either case, the crosslinking treatment is carried out at about 30° C. for 2 to 20 hours. The amount of aldehyde bound to the collagen film after drying is 0.2 to 2.0% by weight for formaldehyde and 0.2% by weight for glutaraldehyde.
It is 2 to 5% by weight.
紫外線ランプは慣用のものでよく、例えば第1表の例で
は三共電機製30Wで波長2537λに鋭く強い、31
30λに弱いそして2965λに非常に弱い放射極大も
つランプが使用された。The UV lamp may be a conventional one; for example, in the example in Table 1, a 30W UV lamp made by Sankyo Denki is sharp and strong against a wavelength of 2537λ, and is 31
A lamp with a weak emission maximum at 30λ and a very weak emission maximum at 2965λ was used.
架橋導入後、水洗された膜は熱風乾燥機内で15分−2
時間乾燥する。乾燥コラーゲンフィルムは一定の大きさ
に切断され必要に応じて多数の小孔をあけ滅菌の後、消
毒用アルコール中に保存される。次に実施例により詳細
に説明する。但し実施例はこの発明の方法を詳細に説明
するためのもので、範囲の限定のためではない。実施例
1
コラーゲン溶液(特公昭46−15033号公報に記載
されている方法によつて製造されたもの〕20部とコラ
ーゲン繊維分散液80部との混合物を原液とし、濃度3
%、PH3.Oで環状細隙0.8n)直径18nのノズ
ルより毎分8mの速度で20℃、23%食塩水溶液中に
管状に吐出して凝固させコラーゲンフィルムを得た。After introducing crosslinking, the water-washed membrane was placed in a hot air dryer for 15 minutes.
Dry for an hour. The dried collagen film is cut to a certain size, a number of small holes are made as necessary, and after sterilization, it is stored in disinfectant alcohol. Next, a detailed explanation will be given using examples. However, the examples are intended to explain the method of the present invention in detail, and are not intended to limit the scope. Example 1 A mixture of 20 parts of collagen solution (manufactured by the method described in Japanese Patent Publication No. 46-15033) and 80 parts of collagen fiber dispersion was used as a stock solution, and the concentration was 3.
%, PH3. The mixture was discharged into a 23% saline solution at 20° C. into a tubular shape at a speed of 8 m/min from a nozzle with an annular gap of 0.8 nm and a diameter of 18 nm to obtain a collagen film.
この管状体に空気を吹き込み膜をふくらませ、膜の上下
に30Wの紫外線殺菌灯を1本ずつおき管状体を回転さ
せながら前記第1表のUV−1の条件で架橋結合を導入
した。コラーゲンフィルムの厚さは0.05nであつた
。これを5×5cnLの大きさに切断し、直径0.11
の穴を41個あけ、ジャケット付の耐圧チャンバー中に
入れ、力ボックス20(エチレンオキサイドニ炭酸ガス
ニ20:80)雰囲気中で40℃で2気圧で5時間滅菌
した後、消毒用アルコール中に保存した。実施例2
コラーゲン溶液(特公昭−37−14426号公報に記
載されている方法によつて製造されたもの)50部とコ
ラーゲン繊維分散液50部との混合物を原液とし、濃度
5%、PH3.Oで細隙0.8欝町巾55nのスリット
ノズルより毎分8mの速度で23%食塩水溶液中に吐出
、凝固させた。Air was blown into the tubular body to inflate the membrane, and one 30 W ultraviolet germicidal lamp was placed above and below the membrane, and the tubular body was rotated to introduce crosslinking under the UV-1 conditions shown in Table 1 above. The thickness of the collagen film was 0.05n. Cut this into a size of 5 x 5 cnL, diameter 0.11
41 holes were made in the sample, placed in a jacketed pressure chamber, sterilized in a force box 20 (ethylene oxide, carbon dioxide, 20:80) atmosphere at 40°C and 2 atm for 5 hours, and then stored in rubbing alcohol. did. Example 2 A mixture of 50 parts of a collagen solution (manufactured by the method described in Japanese Patent Publication No. 37-14426) and 50 parts of a collagen fiber dispersion was used as a stock solution, and the concentration was 5% and the pH was 3. The mixture was discharged into a 23% saline solution at a rate of 8 m/min through a slit nozzle with a slit of 0.8 mm and a width of 55 nm under O, and solidified.
これを第1表F−2の処方により架橋を導入し、50×
50nの大きさに切断し穴を開けずに実施例1と同様の
方法で滅菌した。コラーゲンフィルムの厚さは0.08
nuであり、ホルムアルデヒドの結合量は1.5%であ
つた。実施例3
実施例2で使用したコラーゲン溶液を単独で使用して原
液とし、濃度5%、PH3.Oで細隙0.8n)巾55
nのスリットノズルより毎分8mの速度で23%食塩水
溶液中に吐出、凝固させた。Crosslinking was introduced into this according to the recipe shown in Table 1 F-2, and 50×
It was cut into a size of 50 nm and sterilized in the same manner as in Example 1 without making holes. The thickness of collagen film is 0.08
nu, and the amount of formaldehyde bound was 1.5%. Example 3 The collagen solution used in Example 2 was used alone to prepare a stock solution with a concentration of 5% and a pH of 3. Slit 0.8n) Width 55
It was discharged into a 23% saline solution from a slit nozzle at a speed of 8 m/min and solidified.
これを第1表G−1の処分で架橋を導入した。乾燥後、
50×50nの大きさに切断し、0.15nφの穴を4
1個あけ実施例1と同様に滅菌した。グルタルアルデヒ
ドの結合量は0.9%であつた。実施例4特公昭46−
15033号公報に記載された方法によつて得たコラー
ゲン溶液を単独で原液とし、濃度0.5%PH3.Oで
風乾法によりコラーゲンフィルムを得た。Crosslinking was introduced into this by the treatment shown in Table 1 G-1. After drying,
Cut into a size of 50 x 50n and make 4 holes of 0.15nφ.
One piece was opened and sterilized in the same manner as in Example 1. The amount of glutaraldehyde bound was 0.9%. Example 4 Special Public Service 1977-
The collagen solution obtained by the method described in Publication No. 15033 was used alone as a stock solution, and the concentration was 0.5% PH3. A collagen film was obtained by air-drying at O.
厚さは0.11薦であつた。これを50×501鵞の大
きさに切断し直径1.5mnの穴を25個あけた。架橋
反応は第1表のF−1を用いた。ホルムアルデヒド結合
量は0.6%であつた。乾燥後コラーゲンフィルムはジ
ャケット付の耐圧チャンバー中に入れて力ボックス20
(エチレンオキサイドニ炭酸ガスニ20:80)の中で
40℃、2気圧で5時間滅菌し、その後消毒用アルコー
ル中に保存した。以上の方法でフィルムタイプのコラー
ゲン製人工皮膚を調整し種々の生物実験を行つたが、い
ずれの方法による製品も大差なく十分な治療効果を得た
。The thickness was 0.11 mm. This was cut into a size of 50 x 501 mm, and 25 holes with a diameter of 1.5 mm were drilled. F-1 in Table 1 was used for the crosslinking reaction. The amount of formaldehyde bound was 0.6%. After drying, the collagen film was placed in a jacketed pressure chamber and placed in a force box 20.
It was sterilized in (ethylene oxide/carbon dioxide 20:80) at 40° C. and 2 atm for 5 hours, and then stored in rubbing alcohol. Film-type collagen artificial skin was prepared using the above method and various biological experiments were conducted, and the products obtained by each method achieved sufficient therapeutic effects without much difference.
そのうち、特に実施例1,2によつて製造されたコラー
ゲンフィルムについて、臨床試験の結果を参考例として
述べる。参考例1
生後6ケ月の男子の手背部熱傷■度で表皮は完全に壊死
しており、めくれ上つていたが実施例1で製造されたコ
ラーゲンフィルムを直接あててその上に滅菌ガーゼをの
せておおい更に包帯で固定した。Among these, the results of clinical tests will be described as reference examples, particularly regarding the collagen films produced in Examples 1 and 2. Reference Example 1: A 6-month-old boy had severe burns on the back of his hand. The epidermis was completely necrotic and was peeling up, but the collagen film produced in Example 1 was applied directly and sterile gauze was placed on top. I fixed it with a bandage.
ガーゼは毎日交換し、傷の治癒経過を観察したが経過は
非常に良好であり、15日目に廠痕等なく、上皮化した
。参考例2
4才の男子の前腕熱傷■度であるが、実施例2で製造さ
れたコラーゲンフィルムを参考例1と同様に応用したと
ころ、6日目には創傷部は乾燥し、上皮が形成され、1
7日目には廠痕等なくきれいに治癒した。The gauze was changed every day, and the progress of healing of the wound was observed, and the progress was very good. On the 15th day, epithelialization occurred without any scars. Reference Example 2 A 4-year-old boy had a degree of forearm burn. When the collagen film produced in Example 2 was applied in the same manner as Reference Example 1, the wound area dried and epithelium was formed on the 6th day. and 1
On the 7th day, the wound was completely healed without any scars.
観察の結果と考察
以上のようにフィルムタイプのコラーゲン製人工皮膚の
特徴は創傷面に刺激を与えず創面の浸出液を排出して創
面を細菌感染や異物の刺激から守り又特に異常な異物反
応や炎症反応も認められず、コラーゲンという生物材料
であるため、生体になじみ全般的に従来使われていたも
のに比べて治癒が早いという事である。Observation results and discussion As mentioned above, the characteristics of the film-type artificial skin made of collagen are that it does not irritate the wound surface, drains the exudate from the wound surface, protects the wound surface from bacterial infection and stimulation by foreign substances, and especially prevents abnormal foreign body reactions. No inflammatory reactions are observed, and because it is made from a biological material called collagen, it is compatible with the body and generally heals more quickly than conventionally used materials.
Claims (1)
からなり、両者に含有されるコラーゲンの割合が80−
0対20−100(乾燥重量比)である0.2−6%の
原料を濃厚無機塩類水溶液中に管状または平面状に押出
して凝固させるか風乾法によりフィルムを作つた後、ア
ルデヒド類を用いて架橋することを特徴とする、フィル
ムタイプのコラーゲン製人工皮膚の製造法。 2 コラーゲン繊維の水系分散液とコラーゲン水溶液と
からなり、両者に含有されるコラーゲンの割合が80−
0対20−100(乾燥重量比)である0.2−6%の
原液を濃厚無機塩類水溶液中に管状または平面状に押出
して凝固させるか風乾法によりフィルムを作つた後、紫
外線を照射して架橋することを特徴とする、フィルムタ
イプのコラーゲン製人工皮膚の製造法。[Claims] 1. Consisting of an aqueous dispersion of collagen fibers and an aqueous collagen solution, the proportion of collagen contained in both is 80-
0:20-100 (dry weight ratio) of 0.2-6% raw material is extruded into a concentrated inorganic salt aqueous solution in a tubular or flat shape and coagulated, or a film is made by an air drying method, and then aldehydes are used. A method for producing a film-type collagen artificial skin characterized by crosslinking. 2 Consisting of an aqueous dispersion of collagen fibers and an aqueous collagen solution, the proportion of collagen contained in both is 80-
A 0:20-100 (dry weight ratio) stock solution of 0.2-6% is extruded into a concentrated inorganic salt aqueous solution in a tubular or planar shape and coagulated, or a film is made by an air-drying method, and then ultraviolet rays are irradiated. A method for producing a film-type collagen artificial skin characterized by crosslinking.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50057870A JPS5913210B2 (en) | 1975-05-15 | 1975-05-15 | Method for manufacturing film-type collagen artificial skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP50057870A JPS5913210B2 (en) | 1975-05-15 | 1975-05-15 | Method for manufacturing film-type collagen artificial skin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS51133998A JPS51133998A (en) | 1976-11-20 |
| JPS5913210B2 true JPS5913210B2 (en) | 1984-03-28 |
Family
ID=13068006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50057870A Expired JPS5913210B2 (en) | 1975-05-15 | 1975-05-15 | Method for manufacturing film-type collagen artificial skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5913210B2 (en) |
-
1975
- 1975-05-15 JP JP50057870A patent/JPS5913210B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS51133998A (en) | 1976-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100847417B1 (en) | Method for producing collagen sponge, apparatus for extracting collagen foam part, and elongated collagen sponge | |
| US7098315B2 (en) | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge | |
| US4089333A (en) | Method of treating a wound or burn | |
| JPH0636815B2 (en) | Method for producing cellulose film as a substitute for artificial film | |
| US3847155A (en) | Methods for the elimination of scars using copolymer films in place of surgical sutures | |
| CN107812230B (en) | Dismantling-free antibacterial operation suture line and preparation method thereof | |
| CN110639050A (en) | Silk fibroin nanofiber and preparation method of silver-loaded antibacterial dressing based on silk fibroin nanofiber | |
| CN112007200B (en) | Antibacterial repair-promoting hemostatic anti-adhesion membrane and preparation method thereof | |
| JPH0461862A (en) | Collagen fiber hemostatic material and its manufacture | |
| CN108452366B (en) | A kind of cod skin gelatin composite hemostatic dressing and preparation method thereof | |
| CN107137758B (en) | A kind of microfiber collagen hemostatic material and preparation method thereof | |
| CN103083721B (en) | Artificial skin graft for genipin immobilized activin B and preparation method thereof | |
| CN1021953C (en) | Collagen-polyvinyl alcohol suture and its production method | |
| CN1775302A (en) | Preparation method of chitosan-gelatin sponge wound dressing | |
| JPS5913210B2 (en) | Method for manufacturing film-type collagen artificial skin | |
| TWI414323B (en) | Composition film, the process for the production thereof and use thereof | |
| RU2789304C1 (en) | Biodegradable wound-healing film | |
| TWI334878B (en) | Degradable dressing for wound healing appilcation | |
| CN117414462B (en) | Hemostatic granules for diffuse bleeding and preparation method and application thereof | |
| JP2005013457A (en) | Molding obtained from fish-derived collagen and its thermal denaturation material | |
| CN116672491B (en) | A self-healing hydrogel dressing, its preparation method and application | |
| CN117919502A (en) | A method for preparing collagen-based biomedical material | |
| JPS5852662B2 (en) | Seizouhou | |
| KR20160142758A (en) | Manufacturing method of collagen film using ultraviolet rays and collagen film manufactured by using the same and biomaterials manufactured by using the collagen film | |
| CN118079073A (en) | A jellyfish collagen mixture hydrogel composite functional dressing and its preparation method and application |